Cellular reprogramming factors (Yamanaka factors) (OSKM)

Cellular reprogramming factors, primarily the Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc), are transcription factors that can revert mature, specialized cells into a pluripotent state or partially reset their epigenetic age. These factors act as pioneer factors, binding to condensed chromatin to open up gene loci associated with stemness and self-renewal while silencing lineage-specific genes. In therapeutic contexts, they are being investigated for their ability to rejuvenate aged tissues and organs in vivo, potentially reversing hallmarks of aging and treating degenerative conditions such as heart failure and neurodegeneration. By transiently expressing these factors, researchers aim to restore youthful cellular function without inducing a full transition to pluripotency, which avoids the risk of losing tissue identity. However, the clinical translation of these factors is complicated by significant safety risks, most notably the potential for teratoma formation and the oncogenic activity of factors like c-Myc. To mitigate these risks, current pharmacological strategies involve the use of small molecule cocktails or modified mRNA to achieve precise, time-limited control over the reprogramming process. Beyond rejuvenation, aberrant tissue reprogramming is also a pathological feature in diseases like Fibrodysplasia Ossificans Progressiva (FOP), where inflammatory signals drive inappropriate cell fate transitions from muscle to bone. Understanding and modulating these factors remains a frontier in regenerative medicine and longevity science.

Other names

Yamanaka factorsOSKM factorsPluripotency factorsTissue reprogramming factorsIn vivo reprogramming factorsCellular rejuvenation factors

Induction of pluripotency or partial cellular reprogramming to restore youthful epigenetic states and promote endogenous tissue repair by modulating signaling pathways (e.g., GSK3, TGF-beta) and epigenetic modifiers (e.g., HDAC, DNMT).